Intravenous immunoglobulin (IVIg) provides protection against endothelial cell dysfunction and death in ischemic stroke
Open Access
- 20 June 2014
- journal article
- Published by Springer Nature in Experimental & Translational Stroke Medicine
- Vol. 6 (1) , 7
Abstract
The brain endothelium is a key component of the blood brain barrier which is compromised following ischemia, allowing infiltration of damaging immune cells and other inflammatory molecules into the brain. Intravenous immunoglobulin (IVIg) is known to reduce infarct size in a mouse model of experimental stroke. Flow cytometry analysis showed that the protective effect of IVIg in ischemia and reperfusion injury in vivo is associated with reduced leukocyte infiltration, suggesting an involvement of the endothelium. In an in vitro model of ischemia, permeability analysis of the mouse brain endothelial cell line bEnd.3 revealed that IVIg prevented the loss of permeability caused by oxygen and glucose deprivation (OGD). In addition, western blot analysis of these brain endothelial cells showed that IVIg prevented the down-regulation of tight junction proteins claudin 5 and occludin and the decline in anti-apoptotic proteins Bcl-2 and Bcl-XL caused by OGD. IVIg protects endothelial cells from ischemic insult. These studies support the use of IVIg as a pharmacological intervention for stroke therapy.Keywords
This publication has 16 references indexed in Scilit:
- Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeCell Death & Disease, 2013
- Regulation of tumor necrosis factor-α–induced microvascular endothelial cell hyperpermeability by recombinant B-cell lymphoma-extra largeJournal of Surgical Research, 2013
- Blood-Brain Barrier Permeability Is Increased After Acute Adult Stroke But Not Neonatal Stroke in the RatThe Journal of Neuroscience, 2012
- Intravenous Immunoglobulins Modulate Neutrophil Activation and Vascular Injury Through FcγRIII and SHP-1Circulation Research, 2012
- Intravenous immunoglobulin protects neurons against amyloid beta‐peptide toxicity and ischemic stroke by attenuating multiple cell death pathwaysJournal of Neurochemistry, 2012
- Intravenous immunoglobulin G (IVIG) inhibits IL-1- and TNF-α-dependent, but not chemotactic-factor-stimulated, neutrophil transendothelial migrationClinical Immunology, 2011
- Intravenous Immunoglobulin Reduces Infarct Volume but Not Edema Formation in Acute StrokeNeuroimmunomodulation, 2009
- Blood-brain barrier tight junction permeability and ischemic strokeNeurobiology of Disease, 2008
- Ambivalent effect of immunoglobulins on the complement system: Activation versus inhibitionMolecular Immunology, 2008
- Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell deathProceedings of the National Academy of Sciences, 2007